from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3055/-

LFCtreatmentdescriptionclass of inhibitor

0.170

Amikacinug/mL Amikacintranslation

0.015

Cap5-10ug/mL Capreomycintranslation

-0.486

Rox10-50 ug/mL Roxithromycintranslation

0.265

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.661

Rif0.2-5ug/mL Rifampicintranscription

0.032

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.402

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.306

CPZ10-50 ug/mL Chlorpromazinerespiration

2.010

Clofazimine10-13 ug/mL Clofaziminerespiration

0.730

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.954

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.042

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.303

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.079

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.064

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.911

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.344

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-0.367

NaN30.2-2 mM Sodium aziderespiration

-0.728

Nigericin50 uM Nigericinrespiration

1.100

TRC10-150 ug/mL Triclosanrespiration

1.474

TRZ10-25 ug/mL Thioridazinerespiration

-0.646

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.082

menadione6-10 ug/mL Menadionerespiration

0.079

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.283

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.221

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.201

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.229

NRP_1Non-replicating persistence stage 1dosRassociated

0.489

Amp0.2mg/mL AmpicillincellWall

-0.369

Cephalexin20-100 ug/mL CephalexincellWall

-0.140

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.774

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.161

EMB10-20 ug/mL EthambutolcellWall

0.024

Eta12-40 ug/mL EthionamidecellWall

0.163

INH0.2-0.4 ug/mL IsoniazidcellWall

0.871

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.497

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.797

BZA0.12 mg/mL BenzamidearomaticAmides

0.308

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.189

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.353

H2O24 mM hydrogen peroxideDNAdamaging

-0.115

Levo10 ug/mL LevofloxacinDNAdamaging

-0.306

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.342

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.061

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.112

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.081

Antimycin12.5-50 ug/mL Antimycin A?

-1.114

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.115

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.117

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.493

PA8240.2-2 ug/mL PA-824?

0.604

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.493

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.297

Verapamil50 uM Verapamil?

-1.153

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.652

methoxatin10-20 ug/mL Methoxatin?